FDA Inspection 1279691 — Olympia Pharmaceuticals

Olympia Pharmaceuticals — FEI 3009724085

The FDA completed an inspection of Olympia Pharmaceuticals on August 8, 2025 in Orlando, FL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 8, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Orlando, FL (United States)

Citations

IDCFRDescription
136121 CFR 211.100(a)Absence of Written Procedures
143521 CFR 211.42(c)(10)(v)Cleaning System
145221 CFR 211.113(b)Validation lacking for sterile drug products